Singapore: Phylogica has engaged Griffin Securities, a specialty investment bank located in New York City, to conduct a formal process for evaluating strategic opportunities... Read more
Singapore: Patrys completed initial treatment of second group of three patients in its phase I/IIa PAT-SM6 multiple myeloma trial. The group was treated in the... Read more
Singapore: Viralytics has finalized the clinical study report on the phase I evaluation of Cavatak, which is administered intravenously to late stage melanoma, prostate,... Read more
Singapore: IDT Australia appointed Dr Paul MacLeman as CEO, effective April 15, 2013. Dr MacLeman was recently the CEO of Melbourne-based biotechnology company Genetic... Read more
Singapore: Starpharma Holdings announced the positive results of its exploratory phase II study of VivaGel for the prevention of recurrent bacterial vaginosis (R-BV).... Read more
Singapore: The IB Australian Bioscience Fund I has generated a unit price of $1.81 for every dollar invested four and a half years ago, prompting its managers to... Read more
Singapore: Prana Biotechnology reported on the progress of its lead development asset PBT2, which is in phase II trials for Huntington disease and Alzheimer's disease.... Read more
Singapore: Australian drug delivery technology company, Phosphagenics, will be returning to the clinic with its oxycodone TPM transdermal patch. The company... Read more
Singapore: Oramed Pharmaceuticals, a developer of oral drug delivery systems, has received approval for a key patent by the Japanese Patent Office. The patent,... Read more
Survey Box
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
